Precision Therapeutics Inc. Business Finance Contracts & Agreements
158 Contracts & Agreements
- Escrow Agreements (1 contract)
- Exchange Agreements (5)
- Forbearance Agreements (2)
- Investor Rights Agreements (1)
- Note Agreements (35)
- Purchase Agreements (24)
- Registration Rights Agreements (7)
- Release Agreements (4)
- Security Agreements (5)
- Stock Agreements (13)
- Subscription Agreements (1)
- Underwriting Agreements (4)
- Warrant Agreements (56)
- Securities Purchase Agreement (Second Offering) (Filed With SEC on May 18, 2022)
- Securities Purchase Agreement (First Offering) (Filed With SEC on May 18, 2022)
- Form of Warrant Amendment Agreement (Filed With SEC on May 18, 2022)
- Form of Placement Agent Warrant (Filed With SEC on May 18, 2022)
- Form of Investor Warrant (Filed With SEC on May 18, 2022)
- Form of Securities Purchase Agreement, dated June 14, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on June 16, 2021)
- Form of Placement Agent Warrant (Filed With SEC on June 16, 2021)
- Form of Warrant (Filed With SEC on June 16, 2021)
- Agreement and Release by and between the Company and Carl Schwartz dated March 19, 2021 (Filed With SEC on March 23, 2021)
- Common Stock Purchase Warrant issued to Oasis Capital, LLC dated March 6, 2020 (50) Exhibit 4.30 (Filed With SEC on March 15, 2021)
- Registration Rights Agreement by and among the Company and the Investors dated February 18, 2021 (Filed With SEC on February 22, 2021)
- Securities Purchase Agreement by and among the Company and the Investors dated February 18, 2021 (Filed With SEC on February 22, 2021)
- Form of Warrant (Filed With SEC on February 22, 2021)
- Form of Securities Purchase Agreement, dated February 10, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on February 12, 2021)
- Form of Warrant (Filed With SEC on February 12, 2021)
- Form of Placement Agent Warrant issued to H.C. Wainwright & Co., LLC or its designees in connection with certain financing transactions in 2020 and 2021 (Filed With SEC on January 29, 2021)
- Form of Securities Purchase Agreement, dated January 21, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on January 26, 2021)
- Form of Warrant (Filed With SEC on January 26, 2021)
- Form of Securities Purchase Agreement, dated January 19, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on January 21, 2021)
- Form of Warrant (Filed With SEC on January 21, 2021)
- Form of Securities Purchase Agreement, dated January 8, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on January 12, 2021)
- Form of Warrant (Filed With SEC on January 12, 2021)
- Form of Warrant dated April 4, 2019 issued in Exchange Offer with Holders of Securities of Helomics Holding Corporation, as amended on September 14, 2020 (Filed With SEC on November 16, 2020)
- Amendment #2 to the Senior Secured Promissory Note originally issued on February 5, 2020 by and among the Company and Oasis Capital, LLC (Filed With SEC on September 30, 2020)
- Amendment #3 to the Senior Secured Promissory Note originally issued on September 27, 2019 by and among the Company and Oasis Capital, LLC (Filed With SEC on September 30, 2020)
- Amendment #5 to the Amended and Restated Senior Secured Promissory Note originally issued on September 28, 2018 by and among the Company and L2 Capital, LLC (Filed With SEC on September 30, 2020)
- Form of Amendment to Common Stock Purchase Warrant (Filed With SEC on September 24, 2020)
- Amendment #1 to the Senior Secured Promissory Note originally issued on February 5, 2020 by and among the Company and Oasis Capital, LLC (Filed With SEC on July 20, 2020)
- Amendment #2 to the Senior Secured Promissory Note originally issued on September 27, 2019 by and among the Company and Oasis Capital, LLC (Filed With SEC on July 20, 2020)
- Amendment #4 to the Amended and Restated Senior Secured Promissory Note originally issued on September 28, 2018 by and among the Company and L2 Capital, LLC (Filed With SEC on July 20, 2020)
- Asset Purchase Agreement, dated July 1, 2020, by and among the Selling Parties and the Company (Filed With SEC on July 7, 2020)
- Form of Warrant Exercise Agreement (Filed With SEC on June 26, 2020)
- Form of New Warrant (Filed With SEC on June 26, 2020)
- Asset Purchase Agreement, dated May 27, 2020, by and among InventaBioTech, Inc., Soluble Therapeutics, Inc., BioDtech, Inc., and Predictive Oncology Inc (Filed With SEC on June 2, 2020)
- Securities Purchase Agreement, dated May 6, 2020, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on May 8, 2020)
- Form of Warrant (Filed With SEC on May 8, 2020)
- Promissory Note dated April 20, 2020 between the Company and Park State Bank (Filed With SEC on May 1, 2020)
- Exchange Agreement dated April 21, 2020 (Filed With SEC on April 22, 2020)
- Amendment #1 to the Senior Secured Promissory Note originally issued on September 27, 2019 by and among the Company and Oasis Capital, LLC (Filed With SEC on March 23, 2020)
- Amendment #3 to the Amended and Restated Senior Secured Promissory Note originally issued on September 28, 2018 by and among the Company and L2 Capital, LLC (Filed With SEC on March 23, 2020)
